|
TPD52 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.19199999554831E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.69353999999178E-05 |
| Normal-vs-Stage2 |
1.94369999995114E-06 |
| Normal-vs-Stage3 |
4.4736000459622E-09 |
| Normal-vs-Stage4 |
2.12440000035841E-07 |
| Stage1-vs-Stage2 |
5.999900E-02 |
| Stage1-vs-Stage3 |
2.454300E-02 |
| Stage1-vs-Stage4 |
5.959700E-02 |
| Stage2-vs-Stage3 |
7.811400E-01 |
| Stage2-vs-Stage4 |
7.371400E-01 |
| Stage3-vs-Stage4 |
9.048200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.2406999999891E-07 |
| Normal-vs-AfricanAmerican |
6.468100E-02 |
| Normal-vs-Asian |
8.19689999986828E-07 |
| Caucasian-vs-AfricanAmerican |
3.069000E-01 |
| Caucasian-vs-Asian |
4.275600E-01 |
| AfricanAmerican-vs-Asian |
2.577400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.47839999926114E-08 |
| Normal-vs-Female |
4.81030000054616E-07 |
| Male-vs-Female |
2.274800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.55779999999806E-05 |
| Normal-vs-Age(41-60Yrs) |
1.81059999992961E-07 |
| Normal-vs-Age(61-80Yrs) |
8.42109999510399E-08 |
| Normal-vs-Age(81-100Yrs) |
1.397440E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.258200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.123150E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.635800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.058600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.369600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.808400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.702200E-01 |
| Classical-VS-Follicular |
1.003800E-01 |
| Classical-VS-Other |
5.371600E-01 |
| Classical-VS-Normal |
1.85679999997745E-06 |
| Tall-VS-Follicular |
3.558800E-01 |
| Tall-VS-Other |
5.291800E-01 |
| Tall-VS-Normal |
9.815900E-04 |
| Follicular-VS-Other |
9.541200E-01 |
| Follicular-VS-Normal |
5.95619999987917E-07 |
| Other-VS-Normal |
1.303550E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.46430000019993E-07 |
| Normal-vs-N1 |
1.9822299999972E-05 |
| N0-vs-N1 |
8.545400E-01 |
|
|
